Abstract: A hand-held aspirating device comprising a main housing having a handle and a barrel, said barrel having a front end and a rear portion, said handle having a lower end and an upper end communicating with said rear portion of said barrel; actuating means extending from said main housing beneath said barrel, means operatively associated with said actuating means to normally maintain said actuating means in an extended position, said actuating means being actuable in a direction generally parallel to said barrel to move said actuating means rearwardly toward said handle; suction means including a suction chamber disposed within said housing and responsive to the actuation of said actuating means for creating a suction within said suction chamber; a container means for receiving aspirate, said container means being removably connected to said handle; a first conduit within said housing, said first conduit having two ends, one of said ends normally being in fluid-flow communication with said container means and th

Abstract: Multiple sclerosis is treated by the administration of azaspirane compounds, either germanium or silicon asaspirane compounds, preferably spirogermanium, most preferably dimethyl, diethyl, dipropyl or dibutyl. The diethyl or dibutyl are the most preferred.

Abstract: Arthritis is treated by administration of azaspirane compounds, either germanium or silicon azaspirane compounds, preferably spirogermanium, most preferably dimethyl, diethyl, dipropyl or dibutyl. The diethyl or dibutyl are the most preferred.

Abstract: An improved accessory or drip pan, and method of making same, is shown and described which is used under heating units of a stove for collecting spilled liquids and foods from pots and pans during cooking.

Abstract: The cholesterol blood level is lowered by administration of a spirogermanium (dimethyl, diethyl, dipropyl or dibutyl, diethyl or dibutyl being preferred).

Abstract: Myocardial infarction is prevented entirely or its severity is reduced in patients subject to the same by administering to such patients after occurrence of coronary occlusion and prior to the setting in of the myocardial infarction of a myocardial infarction preventing effective amount of a beta-(2- or 4-pyridyl-alkyl)-amine or a non-toxic acid addition salt thereof. Such administration acts to help prevent the onset of the myocardial infarction or acts to reduce the size of any formed infarct.